Drug Trial Radar · NCT05702034
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
12,523
Actual
Start
Feb 15, 2023
Primary completion
Oct 15, 2026
Study completion Oct 15, 2026
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- Collaborators
- Bristol Myers Squibb Company (BMS)
- First posted
- Jan 27, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.
Conditions
- Ischemic Stroke; Ischemic Attack, Transient
Interventions
MilvexianDrug
Milvexian will be administered orally.
PlaceboDrug
Placebo will be administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Occurrence of Ischemic StrokeTime frame: Up to global targeted endpoint date (approximately 41 months)
Locations
880 sites in 47 countries. Site status is shown where the registry gives one.
Banner Desert Medical Center
Mesa, Arizona
University of Arizona
Tucson, Arizona
Plaza Neuroscience Clinic
Fayetteville, Arkansas
Alta Bates Medical Center Cancer Center
Berkeley, California
Providence Saint Joseph Medical Center - Cancer Center
Burbank, California
Mills Peninsula Health Services
Burlingame, California
Sutter Health - Eden Medical Center
Castro Valley, California
Neurology Center of North Orange County
Fullerton, California
Glendale Adventist Medical Center
Glendale, California
UC Irvine Healthcare Center
Irvine, California
Sharp Grossmont Hospital
La Mesa, California
Long Beach Memorial
Long Beach, California
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California
Mission Hospital Regional Medical Center
Mission Viejo, California
Hoag Memorial Hospital
Newport Beach, California
Stanford Stroke Center
Palo Alto, California
Kaiser Permanente 1
Redwood City, California
University of California Davis Health System
Sacramento, California
Kaiser Permanente
Sacramento, California
California Pacific Medical Center
San Francisco, California
Pacific Neuroscience Institute
Santa Monica, California
Harbor Ucla Medical Center
Torrance, California
Providence Little Company of Mary
Torrance, California
PIH Health Hospital
Whittier, California
University of Colorado
Aurora, Colorado
Nuvance Health Medical Practices Cardiology Danbury
Danbury, Connecticut
MedStar Georgetown University Hospital
Washington D.C., District of Columbia
MedStar Health Research Institute
Washington D.C., District of Columbia
Boca Raton Regional Hospital
Boca Raton, Florida
Nova Clinical Research, LLC 1
Bradenton, Florida
Nova Clinical Research, LLC
Bradenton, Florida
Morton Plant Hospital
Clearwater, Florida
Baptist Health 1
Miami, Florida
Advent Health Orlando
Orlando, Florida
Sacred Heart Hospital
Pensacola, Florida
Sarasota Memorial Hospital
Sarasota, Florida
Theia Clincial Research, LLC
Temple Terrace, Florida
Saint Marys Medical Center
West Palm Beach, Florida
Augusta University
Augusta, Georgia
Saint Alphonsus Regional Medical Center- Cancer Care Center
Boise, Idaho
Showing 40 of 880 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.